miR‑494‑3p regulates lipopolysaccharide‑induced inflammatory responses in RAW264.7 cells by targeting PTEN

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are key post-transcriptional regulators of cellular processes.
• Inflammatory responses are critical in host defense but can cause tissue damage when dysregulated.
• Macrophages play a central role in innate immunity and inflammatory signaling.

Purpose of the Study:

• To investigate the role of specific miRNAs in lipopolysaccharide (LPS)-induced inflammation in macrophages.
• To identify novel miRNA targets and pathways involved in macrophage inflammatory responses.
• To explore the potential of miRNAs as therapeutic targets for inflammatory diseases.

Main Methods:

• Analysis of the GSE43300 array dataset using the limma package.
• Transfection experiments to overexpress or knockdown miR-494-3p in RAW264.7 macrophages.
• Measurement of proinflammatory cytokine production (IL-1β, TNF-α).
• Bioinformatics prediction and luciferase assays to identify miRNA targets.
• Western blotting to assess protein levels and signaling pathway activation (p65, AKT).

Main Results:

• miR-494-3p was upregulated in LPS-treated macrophages.
• Overexpression of miR-494-3p suppressed LPS-induced production of IL-1β and TNF-α.
• Knockdown of miR-494-3p enhanced cytokine production.
• miR-494-3p directly targets PTEN, leading to increased AKT activity.
• miR-494-3p mimics inhibited p65 nuclear translocation, similar to PTEN silencing.

Conclusions:

• miR-494-3p acts as a negative regulator of inflammatory responses in LPS-stimulated macrophages.
• The miR-494-3p/PTEN/AKT pathway is a critical regulator of macrophage activation.
• miR-494-3p represents a potential therapeutic target for managing inflammatory conditions and infections.